Systemic sclerosis: Autologous HSCT is efficacious, but can we make it safer?

Nat Rev Rheumatol. 2018 Apr;14(4):189-191. doi: 10.1038/nrrheum.2018.34. Epub 2018 Mar 8.

Authors

Richard K Burt¹, Dominique Farge²

Affiliations

¹ Division of Immunotherapy, Department of Medicine, Northwestern Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
² Unité Clinique de Médecine Interne, Maladies Auto-immunes et Pathologie Vasculaire, Hôpital St-Louis, AP-HP, Université Denis Diderot, Paris, France.

PMID: 29515186
DOI: 10.1038/nrrheum.2018.34

No abstract available

Publication types

Comment

MeSH terms

Hematopoietic Stem Cell Transplantation*
Humans
Scleroderma, Systemic*
Transplantation, Autologous